Majzner, R., Ramakrishna, S., Mochizuki, A., Patel, S., Chinnasamy, H., Yeom, K., … Monje, M. (2021). EPCT-14. GD2 CAR T-CELLS MEDIATE CLINICAL ACTIVITY AND MANAGEABLE TOXICITY IN CHILDREN AND YOUNG ADULTS WITH H3K27M-MUTATED DIPG AND SPINAL CORD DMG. In Neuro-Oncology (Vol. 23, pp. i49–i50). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noab090.200

Majzner, Robbie, Sneha Ramakrishna, Aaron Mochizuki, Shabnum Patel, Harshini Chinnasamy, Kristen Yeom, Liora Schultz, et al. “EPCT-14. GD2 CAR T-CELLS MEDIATE CLINICAL ACTIVITY AND MANAGEABLE TOXICITY IN CHILDREN AND YOUNG ADULTS WITH H3K27M-MUTATED DIPG AND SPINAL CORD DMG.” In Neuro-Oncology, 23:i49–50. Oxford University Press (OUP), 2021. https://doi.org/10.1093/neuonc/noab090.200.

Majzner R, Ramakrishna S, Mochizuki A, Patel S, Chinnasamy H, Yeom K, et al. EPCT-14. GD2 CAR T-CELLS MEDIATE CLINICAL ACTIVITY AND MANAGEABLE TOXICITY IN CHILDREN AND YOUNG ADULTS WITH H3K27M-MUTATED DIPG AND SPINAL CORD DMG. In: Neuro-Oncology. Oxford University Press (OUP); 2021. p. i49–50.

Majzner, Robbie, et al. “EPCT-14. GD2 CAR T-CELLS MEDIATE CLINICAL ACTIVITY AND MANAGEABLE TOXICITY IN CHILDREN AND YOUNG ADULTS WITH H3K27M-MUTATED DIPG AND SPINAL CORD DMG.” Neuro-Oncology, vol. 23, no. Supplement_1, Oxford University Press (OUP), 2021, pp. i49–50. Crossref, doi:10.1093/neuonc/noab090.200.

Majzner R, Ramakrishna S, Mochizuki A, Patel S, Chinnasamy H, Yeom K, Schultz L, Richards R, Campen C, Reschke A, Mahdi J, Toland AMS, Baggott C, Mavroukakis S, Egeler E, Moon J, Landrum K, Erickson C, Rasmussen L, Barsan V, Tamaresis J, Marcy A, Kunicki M, Fujimoto M, Ehlinger Z, Kurra S, Cornell T, Partap S, Fisher P, Grant G, Vogel H, Sahaf B, Davis K, Feldman S, Mackall C, Monje M. EPCT-14. GD2 CAR T-CELLS MEDIATE CLINICAL ACTIVITY AND MANAGEABLE TOXICITY IN CHILDREN AND YOUNG ADULTS WITH H3K27M-MUTATED DIPG AND SPINAL CORD DMG. Neuro-Oncology. Oxford University Press (OUP); 2021. p. i49–i50.